Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aimmune Therapeutics Inc.

www.aimmune.com

Latest From Aimmune Therapeutics Inc.

As US FDA Settles Into Teleworking, Will Application Reviews Be Affected?

Productivity may suffer under coronavirus-mandated telework despite workforce diligence, experts say.

Coronavirus COVID-19 Drug Review

Bad For Pharma: Sales Reps And Patients Are Staying Home

Industry is limiting face-to-face interactions between sales reps and physicians, and some patients are sitting out visits, amid the COVID-19 outbreak. That poses big business challenges for pharma.

Advertising, Marketing & Sales Coronavirus COVID-19

Coronavirus Update: Drug Launches Could Be Hit, New Twist In CureVac Controversy, Moderna Doses First Patient

As western Europe and the US roll out the next wave of lockdown measures to limit the spread of COVID-19, biopharma is continuing efforts to accelerate therapies and vaccines, including Moderna starting Phase I trials.

International Companies

Palforzia Peanut Allergy Immunotherapy: Aimmune CEO On REMS Restrictions, Manufacturing

Aimmune CEO Jayson Dallas tells the Pink Sheet how physicians and patients are being certified to use Palforzia and how the product's food-based manufacturing process is actually an advantage. 

Safety Manufacturing
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Immune Disorders
  • Alias(es)
  • Allergen Research Corp.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Aimmune Therapeutics Inc.
  • Senior Management
  • Jayson Dallas, Pres. & CEO
    Eric Bjerkholt, CFO
    Jeffrey H Knapp, PhD, COO
    Daniel C Adelman, MD, CMO
    Mary Rozenman, PhD, SVP, Corp. Dev. & Strategy
  • Contact Info
  • Aimmune Therapeutics Inc.
    Phone: (650) 614-5220
    8000 Marina Blvd.
    Ste. 300
    Brisbane, CA 94005
    USA
UsernamePublicRestriction

Register